Drugs / dl-3-butylphthalide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05976152 | Apr 2024 → Dec 2026 expected | cognitive impairment with or without cerebellar ataxia, stroke disorder | Fudan University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dl-3-butylphthalide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05976152 ↗ |
| Route | Oral | “oral Butylphthalide Soft Capsules, 2 capsules/time, tid” NCT05976152 ↗ |